Stem Cells Spin S.A. (WSE:SCS)

Market Cap	11.57M
Revenue (ttm)	57.94K
Net Income (ttm)	-525.25K
Shares Out	41.34M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,126
Average Volume	49,752
Open	0.3220
Previous Close	0.3200
Day's Range	0.3200 - 0.3220
52-Week Range	0.1400 - 0.4300
Beta	0.67
RSI	57.09
Earnings Date	Aug 14, 2025

About Stem Cells Spin

Stem Cells Spin S.A. operates as a biotechnology company in Poland. It engages in the development, cultivation, and application of stem cells using MIC-1 stem cells for human and veterinary medicine, and dermocosmetics applications. The company offers biodermocosmetics under the Revitacell brand name. The company was founded in 2009 and is based in Wroclaw, Poland. Stem Cells Spin S.A. is a subsidiary of Medcervin Sp. z o.o.

• Industry: Biotechnology & Medical Research
• Sector: Healthcare
• Founded: 2009
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: SCS

Financial Performance

In 2024, Stem Cells Spin's revenue was 54,280, a decrease of -87.06% compared to the previous year's 419,322. Losses were -520,267, 237.1% more than in 2023.